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        Peripheral T cell tolerance is mediated in part by 
active processes that maintain a fi  ne balance be-
tween stimulatory and inhibitory signals. Ma-
ture thymocytes exported from the thymus bear 
self-reactivity caused by positive selection on 
self-antigen  –  MHC complexes (  1  ), and naive 
peripheral T cells require tonic interactions with 
self-MHC  –  antigen complexes to persist (  2  –  6  ). 
In conjunction with T cells that can potentially 
recognize self-antigens not presented in the thy-
mus, the inherent avidity of the T cell receptor 
repertoire to self-MHC molecules necessitates 
mechanisms that maintain peripheral self-toler-
ance. Of these, two processes have received the 
bulk of attention: (a) immune suppression by a 
distinct lineage of CD4  +   T cells called natural 
regulatory T (T reg) cells that function in trans 
to inhibit T cell activation (  7  ), and (b) the mod-
ulation of T cell co-stimulatory molecules, espe-
cially those that transmit inhibitory signals in a 
cell-autonomous manner. Cytotoxic T lympho-
cyte antigen-4 (CTLA-4; CD152), a structural 
homologue of the primary positive co-stimula-
tory molecule CD28, is the most extensively 
studied inhibitory T cell molecule essential for 
T cell homeostasis and tolerance induction 
(  8, 9  ). Mice defi  cient in CTLA-4 develop a fatal 
lymphoproliferative disorder (  10, 11  ) with aber-
rant T cell activation evident by 4 d after birth. 
Because development, selection, and peripheral 
TCR repertoire complexity appear grossly nor-
mal in   Ctla4       /         mice (  12  –  14  ), the aberrant acti-
vation is most likely initiated by unchecked 
recognition of self- or environmental antigens in 
peripheral tissues. 
  In conventional T cells, CTLA-4 can dampen 
stimulatory signals by at least three major mec-
hanisms. First, it effi   ciently competes with the 
positive co-stimulatory molecule CD28 for their 
shared ligands, B7.1 and B7.2 (  15, 16  ). Second, 
CTLA-4 transduces negative signals that induce 
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  Cytotoxic T lymphocyte antigen-4 (CTLA-4) plays a critical role in negatively regulating 
T cell responses and has also been implicated in the development and function of natural 
FOXP3  +   regulatory T cells. CTLA-4  –  defi  cient mice develop fatal, early onset lymphoprolif-
erative disease. However, chimeric mice containing both CTLA-4  –  defi  cient and   –  suffi  cient 
bone marrow (BM)  –  derived cells do not develop disease, indicating that CTLA-4 can act in 
trans to maintain T cell self-tolerance. Using genetically mixed blastocyst and BM chimaeras 
as well as in vivo T cell transfer systems, we demonstrate that in vivo regulation of   Ctla4        /      
T cells in trans by CTLA-4  –  suffi  cient T cells is a reversible process that requires the persis-
tent presence of FOXP3  +   regulatory T cells with a diverse TCR repertoire. Based on gene 
expression studies, the regulatory T cells do not appear to act directly on T cells, suggesting 
they may instead modulate the stimulatory activities of antigen-presenting cells. These 
results demonstrate that CTLA-4 is absolutely required for FOXP3  +   regulatory T cell func-
tion in vivo. 
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  In this study, we use mixed stem cell chimaeras and T cell 
transfer systems to defi  ne the cellular and molecular mecha-
nisms involved in trans-regulation of CTLA-4  –  defi  cient T 
cells. We demonstrate that regulation: (a) is exclusively medi-
ated by CTLA-4  –  suffi   cient T reg cells with a diverse TCR 
repertoire; (b) is reversible and depends on the continuous 
presence of T reg cells; (c) is not dependent on   “  reverse in-
side-out  ”   B7 signaling (  31, 32  ); and (d) is unlikely to involve 
direct and unique molecular alterations of   Ctla4       /         T cells by 
T reg cells and their eff  ector molecules. Collectively, these 
results demonstrate that T reg cells can dominantly control a 
large pool of self-reactive T cells in vivo and that CTLA-4 is 
essential for their cell function. 
    RESULTS   
  CTLA-4  –  suffi  cient blastocyst and BM-derived cells stably 
regulate   Ctla4      /        T cells in vivo 
    Ctla4       /         mice develop massive lymphoproliferation and a 
multi-organ infl  ammatory response driven by self-antigen 
specifi  c T cells (  10, 11  ). Peripheral T cells are detectably acti-
vated by 4 d of age, and transfer of T cells from   Ctla4       /         mice 
to lymphopenic hosts such as   Rag1       /         mice recapitulates the 
disease (wasting and lymphoproliferation), highlighting the 
autoaggressive nature of   Ctla4       /         T cells (unpublished data). 
As initially shown by Bachmann et al. (  22  ), BM chimaeras 
generated using a 1:1 mixture of wild-type and   Ctla4       /         
(WT:  Ctla4       /        ) cells are protected from disease and remained 
healthy for extended periods of time (  Fig. 1 A  ).   This contrasts 
with  Ctla4       /        -only BM chimaeras that succumb to a fatal lym-
phoproliferative and infl  ammatory disease. Similarly, mixed 
WT:  Ctla4       /         blastocyst chimaeras generated without any ma-
nipulation of the lymphoid microenvironment (e.g.,     -irradi-
ation performed on BM recipients) were also disease resistant 
for their entire life span. (  Fig. 1, A and B  ). Trans-regu  lation of 
  Ctla4       /         T cells appeared relatively insensitive to the ratio of 
WT:  Ctla4       /         cells as both blastocyst and BM chimaeras with 
WT T cells comprising only 10  –  20% of the peripheral T cell 
compartment, albeit rare, were completely healthy. As initial 
experiments did not reveal any diff  erences between mixed 
blastocyst and BM chimaeras, all subsequent analyses were per -
formed with BM chimaeras. 
  Phenotypically, WT and   Ctla4       /         T cells in the mixed 
BM chimaeras were indistinguishable, with a majority of the 
cells exp  ressing low levels of CD44 and CD69, and high lev-
els of CD62L, which is indicative of a naive/unactivated state 
(  Fig. 1 C  ). In contrast, recipients of   Ctla4       /         BM alone devel-
oped a population of highly activated T cells, comparable to 
  Ctla4       /         mice. The frequency of cycling   Ctla4       /         T cells was 
dramatically reduced in the mixed BM chimaeras, as compared 
with chimaeras receiving   Ctla4       /         BM only (  Fig. 1 C   and not 
depicted), and the naive   Ctla4       /         CD4  +   and CD8  +   T cells 
were as quiescent as WT T cells. Additionally, whereas  Ctla4       /         
only BM chimaeras developed lymphoproliferative disease and 
obvious tissue infi  ltration by activated T cells, WT:  Ctla4       /         
mixed BM chimaeras remained healthy with no aberrant tissue 
infi  ltration or disruption in homeostasis (unpublished data). 
cell cycle arrest and prevent IL-2 secretion (  17  –  20  ). Third, 
CTLA-4 may limit the T cell dwell time with APCs (  21  ). 
Additional complexity in understanding CTLA-4 function 
was revealed by the fi  nding that   Ctla4       /         T cells in mixed 
BM chimaeras remain quiescent in the presence of normal 
(CTLA-4  –  suffi   cient) BM-derived cells (  22  ). How this regu-
lation occurs has not been determined, but T reg cells have 
been suggested to be important, especially because T reg cells 
constitutively express high amounts of CTLA-4. 
  CD4  +   T reg cells arise in the thymus and have been shown 
in vitro and in vivo to dominantly inhibit conventional T cell 
responses to both self- and foreign antigens (  7  ). These cells, 
initially characterized as CD25 (IL-2R    )  +  , are molecularly 
distinguished from other T cell subsets by expression of the 
transcription factor FOXP3 that endows T reg cells with their 
lineage and functional specifi  city (  22, 23  ). As surface expres-
sion of CTLA-4 is generally only detected on T reg cells in 
unmanipulated mice, one interpretation of the mixed BM 
chimaera data were that CTLA-4 is primarily required for T 
reg cell function and/or maintenance and the lymphoprolif-
eration observed in   Ctla4       /         mice is primarily a consequence 
of defective T reg cells. Consistent with this interpretation, 
mice lacking functional T reg cells as a result of a mutation 
in the   Foxp3   gene (  scurfy  ) exhibit pathology quite similar to 
  Ctla4            /          mice (  24  ). Though FOXP3  +   T reg cells with sup-
pressive activity in vitro can be isolated from   Ctla4       /         mice 
(unpublished data) (  25  ), they are clearly incapable of regulat-
ing CTLA-4  –  defi  cient T cells in vivo. 
  Although the role of T reg cells in controlling autoreactive 
  Ctla4       /         T cells in steady-state conditions has not been directly 
addressed, a few reports have investigated the in vivo relevance 
of CTLA-4 on T reg cells by means of an induced colitis model 
(  26  –  28  ). Transfer of naive (CD25       ) CD4  +   T cells into lympho-
penic hosts rapidly leads to colitis unless FOXP3  +  CD4  +  CD25  +   
T reg cells are also transferred. Protection from colitis is abro-
gated by injection of blocking antibody (Ab) against CTLA-4 
suggesting that CTLA-4 is necessary for immune regulation in 
this model system (  28, 29  ). Although the relevant target of Ab 
blockade (e.g., CTLA-4 on eff  ector T cells or T regs) in this 
model was unknown, it has been shown that CTLA-4 block-
ade variably disrupts the control of colitogenic B7-defi  cient 
(  Cd80       /      Cd86       /        )   Clta4       /         T cells by WT (CTLA-4  +  ) T reg 
cells (  30  ), suggesting that CTLA-4 on T reg cells is functionally 
relevant for initiating and/or maintaining regulation. How-
ever, the situation remained uncertain because experiments us-
ing Ab-mediated blockade of CTLA-4 have provided 
inconsistent results in the same model system, and T reg cells 
from   Ctla4       /         mice have also been reported to prevent the 
progression of colitis (  30  ). Given the contrasting observation in 
  Ctla4       /         mice where endogenous T reg cells cannot regulate 
lymphoproliferation of   Ctla4       /         T cells, it is clear that the re-
quirements for regulation may be very distinct between the 
colitis model and CTLA-4 defi  ciency. Hence, the cellular re-
quirements for maintaining tolerance of   Ctla4       /         T cells in a 
steady-state condition in vivo that most closely models physio-
logical peripheral T cell tolerance to self are not known. JEM VOL. 206, February 16, 2009 
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cell compartment upon robust activation and chronic antigen 
presentation was also observed in mixed BM chimaeras chal-
lenged with skin allografts (unpublished data). 
  CTLA-4  –  suffi  cient          T cells actively regulate   Ctla4      /        
T cells in the periphery 
  The WT BM-derived cell subset responsible for trans-regu-
lating   Ctla4       /         T cells has not been formally demonstrated. 
To this end, we fi  rst generated   Tcrb        /     :  Ctla4       /         mixed BM 
chimaeras to confi  rm that          T cells are required. The absence 
of WT          T cells led to the expansion of activated   Ctla4       /         
T cells and death of the animals, demonstrating their require-
ment for regulation (  Table I  ).   In addition, CTLA-4  –  suffi   cient 
         T cells expressing MHC class I  –   or class II  –  restricted 
TCR transgenes in a RAG-1/2  –  suffi   cient background (that 
allows for the generation of FOXP3  +   T cells) were unable to 
prevent   Ctla4       /         T cell expansion in mixed chimaeras (  Fig. 2  ), 
suggesting that a diverse TCR repertoire is required for 
the regulation.   Further,   Tcrd        /     :C  tla4       /         mixed chimaeras 
  The robustness of the trans-regulation in WT:  Ctla4       /         
mixed BM chimaeras was tested in both acute viral (lympho-
cytic choriomeningitis virus [LCMV]) and chronic   Mycobac-
terium tuberculosis   (  Mtb  ) models, which primarily elicit CD8  +   
or CD4  +   T cell responses, respectively (  33  –  36  ). The fre-
quency and magnitude of antiviral or antibacterial T cell re-
sponses in challenged WT:  Ctla4       /         mixed BM chimaeras 
were essentially identical between WT and   Ctla4       /         T cells 
(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20081811/DC1, and not depicted). The results with 
LCMV infection confi  rmed previously published studies (  37, 
38  ). In the case of chronic   Mtb   infection, the WT:  Ctla4       /         
ratio of T cells in the lung and spleen upon analysis was simi-
lar to preinfection ratios in the blood (Fig. S1 A). Further, the 
proportions of naive, activated, or CD25  +  CD4  +   cells in the 
lung were comparable between WT and   Ctla4       /         T cell 
compartments (Fig. S1 B). Finally, in vitro IFN-     responses 
to   Mtb   antigens by WT and   Ctla4       /         T cells from infected 
mixed BM chimaeras showed no signifi  cant diff  erences (un-
published data). This remarkable stability of the   Ctla4       /         T 
    Figure 1.           Ctla4  +/+     cells can regulate   Ctla4      /        T cells in mixed BM and blastocyst chimaeras.   (A) Healthy   Rag1     /       mice received a total of    4   ×  
10  6   T cell  –  depleted BM cells from 2  –  3-wk-old   Ctla4     /       mice (KO only) or a 1:1 mix from   Ctla4     /       and WT mice (KO:WT). Blastocyst chimaeras were gen-
erated as per Materials and methods, and all chimaeras were monitored for disease incidence. Mice were considered healthy (% Healthy) if no evidence of 
prolonged weight loss (  >  2 wk), ruffl  ed fur, hunched posture, or skin or eye infl  ammation were visible. Mice were also bled periodically to measure relative 
KO:WT T cell ratios.   Ctla4     /      -only recipients were killed for ethical reasons by 8 wk of age. (B) 12 blastocyst chimaeras, each line representing individual 
mice, were periodically bled over several years, and the frequency of   Ctla4     /       T cells among total T cells enumerated via fl  ow cytometry. (C) 6  –  8-wk-old 
KO only or KO:WT chimaera groups were killed, and LN cells were isolated and analyzed for expression of activation markers CD44, CD62L, CD69, and 
incorporation of the thymidine analogue BrdU, by fl  ow cytometry. Results gated on CD4  +   LN T cells from representative chimaeras are shown. Data 
shown in A and C are representative of over a dozen experiments. Data in B are the cumulative results of at least three experiments.   424 T REG CELLS REQUIRE CTLA-4 FOR TRANS-REGULATION   | Friedline et al. 
regulation or that CD4       CD8        T cells may be responsible. 
Interpretation of these results was hampered by the fact that 
lack of CD8 or CD4 coreceptors does not preclude the de-
velopment of T cells positively selected on MHC class I or 
class II molecules, respectively (  44, 45  ) (see below). 
  Given the requirement for TCR    -expressing cells and a 
possible involvement of CD4       8                 TCR  +   T cells, it was 
formally possible that NKT cells were responsible for regula-
tion. To test this, WT:  Ctla4       /         mixed chimaeras were in-
jected weekly with PK136 mAb that has been shown to 
deplete NK1.1-expressing cells (NKT and NK cells) in vivo 
(  46  ). NK1.1  +   cell-depleted WT: Ctla4       /         chimaeras remained 
healthy for 2 mo, and analyses of lymphocytes in the treated 
mice confi  rmed that   Ctla4       /         T cells remained quiescent 
(unpublished data). Thus, NKT and NK cells are not re-
quired for trans-regulation. 
  Depending on the model system, induction of T cell tol-
erance has been demonstrated to have short- or long-lived 
consequences on subsequent T cell responses. The question 
therefore arises whether tolerance in this model system is ir-
reversible such that, once established, regulation no longer 
requires continuous suppression by WT T cells. To address 
this we fi  rst tested whether the established in vivo regulation 
of   Ctla4       /         T cells in mixed BM chimaeras could be re-
versed by the selective depletion of WT T cells. To this end, 
WT:  Ctla4       /        mixed BM chimaeras distinguished by the CD90 
(Thy1) allele were generated. Upon establishing a stable pe-
ripheral T cell repertoire (  >  10 wk after reconstitution), WT 
T cells (CD90.1) were selectively depleted using an anti-
CD90.1  –  specifi  c Ab. To confi  rm eff  ective depletion of WT 
T cells, mice were bled 2 wk after the initiation of Ab admin-
istration. By this time,   >  90% of T cells in both the CD4  +   and 
CD8  +   subsets were CD90.2  +  , indicating eff  ective depletion 
of CD90.1  +   WT T cells (unpublished data). 
  3  –  4 wk after initiating depletion, mice began to show 
symptoms of sickness similar to   Ctla4       /        -only BM recipients 
(ruffl   ed fur, infl  ammation around the ears and eyes, and loose 
stools indicative of enterocolitis). In contrast, CD90.1 WT: 
CD90.2 WT control chimaeras that were depleted of CD90.1  +   
WT cells showed no visible signs of illness and appeared 
healthy throughout the study. Animals were killed 8 wk after 
WT T cell depletion, and lymphocytes were analyzed for ac-
tivation status as shown in   Fig. 3 A  .   Most T cells from the 
WT (CD90.1)-depleted WT:  Ctla4       /         mixed BM chimaeras 
were activated (CD44  hi  CD69  +  CD62L  lo  ) in contrast to the 
depleted WT:WT, which maintained a predominantly naive 
phenotype. Furthermore, almost a third of the   Ctla4       /         cells 
were now cycling, as indicated by the threefold increase in 
total LN and spleen cell numbers, primarily in the CD4  +   T 
cell compartment. (  Fig. 3 B  ). This contrasts with WT T cells 
from depleted control chimaeras that had a relatively low fre-
quency of cycling cells. Histological analyses confi  rmed that 
  Ctla4       /         T cells had regained overt autoreactive characteris-
tics as indicated by infi  ltration into various nonlymphoid or-
gans (unpublished data). These data reveal that trans-regulation 
depends on the persistent presence of WT T cells and that the 
remained healthy, indicating that          T cells are not necessary 
for regulation. 
  We next addressed whether regulation required the activ-
ity of a specifi  c          T cell subset. As both CD4  +   (  39  –  41  ) and 
CD8  +   (  42, 43  ) regulatory T cells have been reported, we ex-
amined whether the absence of either of these WT T cell 
subsets aff  ected tolerogenic potential in mixed BM chimaeras. 
For these experiments, mixed chimaeras consisting of CD4- 
or CD8-defi  cient along with   Ctla4       /         BM-derived cells 
were generated. CTLA-4  –  suffi   cient   Cd4          /         or   Cd8          /         BM 
cells were able to regulate   Ctla4            /          T cells in mixed BM 
chimaeras, as most recipient chimaeras remained healthy for 
  >   6 mo (Table I). Also, no signifi  cant phenotypic diff  erences 
were detected between the   Ctla4       /         and CTLA-4  +   T cells in 
the respective chimaeras (not depicted). This data initially sug-
gested either that CD4  +   or CD8  +   T cells were suffi   cient for 
    Table I.       Functional        +   T cells are required for regulating 
  Ctla4     /       T cells in mixed BM chimaeras 
Source of regulatory cells    a   Rescue  frequency    b   
  TCRd      /       :  Ctla4      /       6/6
  TCRb      /       :  Ctla4      /       0/5
  Cd4      /       :  Ctla4      /       7/8
  Cd8      /       :  Ctla4      /       4/5
  Cd28      /       :  Ctla4      /       0/15
  wt:  B7     /       Ctla4      /       4/4
  a  1:1 mixed BM chimaeras of indicated genotypes, except for those involving 
  Cd28     /       BM cells where some were at a 3:1 ratio (  n   = 5). Control mixed chimaeras 
receiving   Ctla4  +/+    instead of   Ctla4     /       BM remained healthy (not depicted).
  b  Frequency of surviving mice with quiescent   Ctla4  -/-    T  cells.
    Figure 2.         A diverse repertoire of   Ctla4  +/+     T cells are required to 
regulate   Ctla4      /        T cells in vivo.   Rag1     /       recipient mice received a 
total of    4   ×   10 6   T cell  –  depleted BM cells from a 1:1 mix of   Ctla4     /       and 
WT mice (KO:WT), or   Ctla4     /       and 2CT, OTI, or OTII TCR transgenic Rag1/2-
suffi  cient mice. Some mice received a 1:3 ratio of   Ctla4     /      :OTII BM cells. 
Mice were monitored for disease incidence (% Healthy), as described in 
  Fig. 1 A  . Data are pooled from two independent experiments.     JEM VOL. 206, February 16, 2009 
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by the depletion of the WT T cells. However, this seems un-
likely given the rapid kinetics of disease (    3 wk) and the 
high proportion of activated peripheral T cells. Moreover, 
transfer of regulated   Ctla4       /         CD4  +   T cells from mixed BM 
regulated   Ctla4       /         T cells are not permanently altered to 
prevent rampant autoreactivity. It is possible that disease in-
duction is mediated solely by recent   Ctla4       /         thymic emi-
grants not subject to peripheral regulatory processes caused 
    Figure 3.           Ctla4      /        T cell quiescence depends on the persistent presence of WT T cells.   (A)  WT :  WT or   Ctla4     /      :WT (KO:WT) mixed BM chimaeras 
received depleting anti-CD90.1 mAb (no treatment control, PBS injected only, and depleted) as indicated in Materials and methods. 8 wk after initiating 
depletion, chimaeras were killed and analyzed. LN cells were isolated and stained for CD44, CD62L, and CD69. Incorporation of the thymidine analogue 
BrdU as a measure of cell turnover was also assayed. Data are gated on CD90.2  +   CD4 +   T cells. (B) Enumeration of T cells from the LN and spleens (SN) of 
depleted mice. Each circle represents individual mice. Data are representative of two independent experiments with at least three chimaeras per group.     426 T REG CELLS REQUIRE CTLA-4 FOR TRANS-REGULATION   | Friedline et al. 
T cells became ill     4 wk after transfer. In contrast, mice re-
ceiving WT CD4  +   T cells with   Ctla4       /         T cells remained 
healthy, with no detectable signs of wasting. In all conditions, 
T cells were CD44  hi  CD62L  lo   because of homeostatic prolif-
eration (  Fig. 4 A  ).   Upon sacrifi  ce, mice receiving   Ctla4       /         
CD4  +   and WT CD8  +   T cells displayed a marked increase in 
T cell number (approximately sixfold) compared with mice 
receiving   Ctla4       /         CD4  +   and WT CD4  +   T cells (  Fig. 4 B  ). 
These data demonstrate that WT CD4  +  , but not CD8  +  , T 
cells are necessary and suffi   cient to regulate   Ctla4       /         T cells. 
Our initial observation of regulation in   Cd4          /        :  Ctla4       /         
mixed chimaeras suggested that non-CD4  +   T cells can regu-
late   Ctla4       /         T cells. However, a more likely interpretation 
attributes regulation to MHC class-II restricted T cells or 
functional FOXP3  +   T cells found in   Cd4       /         mice (unpub-
lished data) (  44, 48  ). 
  CD4  +  25  +   T reg cells regulate   Ctla4      /        T cells in trans 
  Among CD4  +   T cells, CTLA-4  +   FOXP3  +   T reg cells were 
the most likely population necessary for regulating   Ctla4       /         T 
cells. In BM chimaeras consisting of   Cd28       /      :Ctla4       /         cells, 
no trans-regulation was observed (Table I).   Cd28       /         mice 
have approximately fi  vefold reduced number of T reg cells 
(  49  ), but they do not develop autoimmune disease, refl  ecting 
the necessity of CD28 signaling for naive T cell activation. T 
cell composition in   Cd28       /        :WT mixed chimaeras refl  ected 
the initial input ratios, demonstrating that   Cd28       /         T cells are 
not signifi  cantly disadvantaged during reconstitution in the 
presence of WT T cells (unpublished data). These results sug-
gested that either normal T reg cell numbers or CD4  +   T cell 
subsets other than T reg cells with normal CD28 signaling is 
required for the trans-regulation. 
  To directly test the functional relevance of T reg cells, we 
cotransferred WT CD4  +  25  +   T reg cells (  ≥  90% FOXP3  +  ) 
with   Ctla4        /      T cells from healthy mixed BM chimaeras to 
  Rag1       /         recipients in an     1:10 ratio to mimic the normal 
frequency of T reg cells:conventional T cells. Mice receiving 
  Ctla4        /      cells alone became visibly sick by     3-4 wk of age 
despite the fact that    10% of the CD4  +   T cells were FOXP3  +  ; 
the same frequency as the starting donor population (  Fig. 5 A  ).   
In contrast, mice infused with   Ctla4          /         T cells and WT 
T reg cells remained healthy for several months showing no 
signs of lymphoproliferation or aberrant T cell infi  ltration 
into tissues. 
  Comparative analyses of the regulated   Ctla4          /         T cells 
in the transfer system at 3  –  4 wk post-transfer showed that 
the T reg cells suppressed the expansion of both CD4  +   and 
CD8  +     Ctla4            /          T cells. In the spleen and LNs, there was an 
approximately two- and sixfold increase in cell numbers, 
respectively, in mice receiving   Ctla4          /         T cells only com-
pared with those reconstituted with   Ctla4          /         and WT T 
reg cells (  Fig. 5 B  ). The suppression was more pronounced 
for CD4  +   T cells, with     10-fold diff  erence in number in 
the LNs. Given the varying degrees of T cell infi  ltration 
into nonlymphoid tissues in mice receiving only   Ctla4          /         T 
cells (unpublished data), the extent of expansion noted in 
chimaeras into recipients without the appropriate WT T cells 
results in aberrant T cell activation as described below, which 
is consistent with a reversible autoreactive state of   Ctla4       /         T 
cells held in check by CTLA-4  –  suffi   cient T cells. 
  Adoptive transfer of WT CD4  +   T cells maintains regulation 
  Although the BM chimaera system is useful in studying the 
overall development and/or regulation of hematopoetic cells, 
it is diffi   cult to evaluate the importance of specifi  c T cell sub-
sets in the regulation of naive   Ctla4       /         T cells. Instead, adop-
tive transfer of sorted peripheral T cell subsets into lymphopenic 
hosts was chosen to characterize the importance of various T 
cell subsets. Previously, Tivol et al. (  47  ) showed that WT T 
cells rapidly eliminate cotransferred activated   Ctla4       /         T cells 
in the transfer system, suggesting that distinct mechanisms of 
regulation operate on naive versus activated   Ctla4       /         T cells 
in vivo. To avoid this   “  deletional  ”   mechanism of tolerance, 
we sought to isolate naive   Ctla4       /         T cells. Several potential 
in vivo sources of unactivated   Ctla4       /         T cells exist, such as 
day 2 or 3   Ctla4       /         neonates or co-stimulation  –  impaired 
  Ctla4       /         mice (e.g., B7         /      Ctla4       /         or   Cd28       /      Ctla4       /        ). 
However, we deemed these sources problematic because of 
the diffi   culty in obtaining suffi   cient numbers of naive T cells 
from   Ctla4       /         neonates, and in the latter case, because of the 
possibility that T cells from these double-defi  cient mice may 
be abnormal because they are generated and maintained in a 
co-stimulation-defi  cient environment. We therefore chose to 
obtain naive   Ctla4       /         T cells from regulated WT:  Ctla4       /         
mixed BM chimaeras. 
  We fi  rst tested the feasibility of the transfer assay for trans-
regulation of naive T cells by performing bulk transfers of 
LN and/or spleen cells from healthy mixed BM chimaeras to 
  Rag1       /         (or   Tcrb       /        ; similar data not depicted) recipients. 
Although the T cells rapidly up-regulated activation markers 
caused by homeostatic expansion, there was no signifi  cant 
alteration in the relative ratios of WT:  Ctla4       /         T cells and 
no phenotypic diff  erence between the transferred WT or 
  Ctla4       /         T cells (Fig. S2, available at http://www.jem.org/
cgi/content/full/jem.20081811/DC1). The recipient mice 
remained healthy for several months and, unlike transfers us-
ing activated   Ctla4       /         T cells, maintained   Ctla4       /         T cells 
in the periphery, demonstrating effi   cient regulation upon 
transfer. In contrast, transfer of LN/spleen cells depleted of 
WT T cells (using CD90.1 congenic marker) resulted in lym-
phoproliferation and wasting, confi  rming the requirement for 
the continuous presence of WT T cells for regulation (un-
published data). 
  To determine whether regulation could be established by 
either CD4  +   or CD8  +            T cells, sorted CD4  +   T cells from 
WT:  Ctla4       /         mixed BM chimaeras were transferred alone 
(  Ctla4       /         or WT) or together with either WT CD4  +   or 
CD8  +   T cells from C57BL/6 mice. Transfer of naive  Ctla4       /         
(but not WT) CD4  +   T cells alone resulted in lymphoprolifer-
ation and a wasting syndrome (data not shown). WT CD8  +   
T cells were unable to regulate   Ctla4       /         CD4  +   T cells, as 
mice receiving sorted WT CD8  +   T cells and naive   Ctla4       /         JEM VOL. 206, February 16, 2009 
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    Figure 4.         WT CD4  +   T cells regulate   Ctla4      /        T cells in vivo.   CD4 +   or  CD8 +   T cells from WT mice and CD4  +    Ctla4     /       T cells from mixed BM chimaeras 
were sorted and transferred (10  7   cells total) to   Rag1     /       recipients. (A) Representative cytometric data showing the activation profi  le of CD4  +   T cells and 
the frequencies of CD25  +   CD4 +   T cells from each of the three recipient groups (WT CD4  +   T cells alone,   Ctla4     /       CD4 +   and WT CD8  +  , and   Ctla4     /       CD4 +  
and WT CD4  +  ) 3 wk after transfer. (B) Splenic CD4  +   T cell numbers from each group in A. Each group consisted of a minimum of two mice each and is 
representative of three experiments. Error bars denote the SD.     428 T REG CELLS REQUIRE CTLA-4 FOR TRANS-REGULATION   | Friedline et al. 
    Figure 5.         CD4  +  25  +   WT T cells are able to regulate   Ctla4      /        T cells in vivo.   (A) WT T cell  –  depleted LN and spleen cells (KO) from healthy   Ctla4     /    : WT 
mixed BM chimaeras were transferred (2   ×   10  7   cells/mouse) either separately or with purifi  ed WT CD4  + 25 +   T cells (2   ×   10  6   cells/mouse) into   Rag1     /      
recipients. Frequency and activation status of CD4  +   (A) and CD8  +   (C) T cells from the LNs were analyzed in recipients 12 wk after transfer. (B) Quantitation 
of total, CD4  +  , and CD8  +   T cell numbers in the spleen and LN of recipients at the time of analysis. Data are representative of three individual experiments 
with at least three mice per group. Error bars denote the SD.     
lymphoid tissues is most likely an underestimate of the over-
all number of   Ctla4          /         T cells present in the mice. The ac-
tivation status of   Ctla4        /      CD4  +   T cells with our without 
T reg cells revealed negligible diff  erences in CD4  +   T cells, 
most likely as a result of homeostatic proliferation. In con-
trast, the CD8  +   T cell compartment displayed a sig  nificant 
reduction in the frequency of   “  activated  ”   cells (CD44  hi  CD62L       ) 
and an approximately twofold reduction in BrdU uptake when 
CTLA-4  –  suffi   cient T reg cells were cotransferred (  Fig. 5 C  ). 
Collectively, these data demonstrate that CTLA-4  –  suffi   cient, 
but not CTLA-4  –  defi  cient, T reg cells can completely reg-
ulate autopathogenic   Ctla4          /         T cells in vivo. JEM VOL. 206, February 16, 2009 
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  TGF-     or IL-10 is not singularly essential 
for the establishment of trans-regulation 
  The two best-characterized eff  ectors of T reg cells are the cyto-
kines TGF-     and IL-10. Given the absence of alterations in 
TGF-     production by the T cells and candidate TGF-     target 
genes in regulated   Ctla4       /         T cells, trans-regulation appeared 
not to extensively involve suppressive cytokines acting specifi  -
cally on   Ctla4       /         T cells. Consistent with this, WT:  Ctla4       /         
mixed chimaeras injected with blocking Abs to TGF-     had min-
imal alterations at 8 wk of treatment, and even at 3 mo only some 
of the mice showed increased frequency of activated T cells in 
the both WT and   Ctla4        /      populations (unpublished data). 
  Similarly, regulation of   Ctla4       /         T cells also defi  cient in IL-
10 receptor  –  mediated signaling appeared largely intact as mixed 
WT:  Il10ra        /       Ctla4        /      BM chimaeras survived and maintained 
stable T cell subset frequencies (  Fig. 7  ). Interestingly, the 
  IL10ra       /      Ctla4       /         subset had a lower frequency of naive 
T cells in the CD4  +   (  Fig. 7 A  ), and especially in the CD8  +   (  Fig. 
7 B  ) T cell populations, but over time the diff  erences became 
statistically insignifi  cant (data not shown).   Thus, IL-10R signal-
ing in   Ctla4        /      cells is dispensable for the establishment of 
trans-regulation. The functional redundancy of IL-10R signal-
ing and TGF-     and the potential for long-term regulation of 
  Ctla4       /      Il10Ra       /         T cells are currently under investigation. 
    DISCUSSION   
  Using three in vivo model systems, mixed genotype blasto-
cyst chimaeras, mixed BM cell chimaeras, and adoptive T cell 
  B7-mediated signaling in   Ctla4      /        T cells is not required 
for the trans-regulation 
  We next investigated the potential mechanisms involved in 
regulating   Ctla4          /         T cells by CTLA-4  –  suffi   cient T reg cells 
in vivo. Based on the expression of B7.1/2 on activated T cells, 
it has been suggested that CTLA-4 on T reg cells can engage 
its ligand B7 on T cells and directly inhibit their activation 
(  “  inside-out  ”   signal) (  31, 32  ). Although initial reports indi-
cated that B7-defi  cient T cells were resistant to T reg cell  –  me-
diated suppression in vivo, more recent studies using diff  erent 
in vivo models have generated inconsistent data (  30  ). 
  To test whether CTLA-4 suffi   cient T reg cells control 
  Ctla4        /      T cells via B7, we generated mixed BM chimaeras using 
stem cells from WT and   Cd80       /      Cd86       /      Ctla4        /      (B7      /      
Ctla4       /        ) mice. 2 mo after reconstitution, both WT:  Ctla4       /         
and WT:B7      /       Ctla4       /         cohorts were healthy with no signs of 
infl  ammation or wasting (Table I). B7      /       Ctla4       /         T cells in 
the mice were maintained in a naive state, indistinguishable 
from WT cells, as assessed by expression of CD44 and CD62L 
(unpublished data). In conjunction with published data show-
ing that B7      /      and B7      /       Ctla4       /         can be controlled in trans-
fer models by WT T reg cells (  30  ) (unpublished data), the 
regulation of   Ctla4        /      T cells by CTLA-4  –  suffi   cient T reg 
cells in vivo does not require B7 signaling in the T cells. 
  Trans-regulation does not involve signifi  cant molecular 
alterations in   Ctla4        /      T cells 
  Although our data demonstrated that trans-regulation re-
quires the continuous presence of CTLA-4  –  suffi   cient T reg 
cells, it was not known whether they were molecularly alter-
ing the target   Ctla4        /      T cells or inhibiting activation by pre-
venting access to antigens and/or cytokines. To distinguish 
between these possibilities, we performed global gene expres-
sion profi  ling of naive   Ctla4        /      and WT T cells sorted from 
mixed BM chimaeras. 
  Overall, the diff  erences were minimal (    1% of expressed 
genes,     70/6000 assayed; unpublished data) and the gene ex-
pression signature of regulated naive   Ctla4       /         T cells closely 
resembled naive WT T cells from the same animal. At the 
transcriptional level, there was no evidence of active suppres-
sion (  50, 51  ) or altered TCR/CD28 signaling on   Ctla4       /         
T cells. Further analyses of select genes identifi  ed as altered 
in expression by microarray analyses (  Fig. 6  ) revealed that 
  Gadd45        (Myd118) was decreased in expression by approxi-
mately fourfold in   Ctla4        /      T cells compared with the WT 
counterpart, whereas   Gadd45        and   Gadd45        expression were 
not signifi  cantly altered (not depicted).     Gadd45        is required 
for normal responses to TCR and infl  ammatory  cytokine 
stimulations as indicated by the development of autoimmu-
nity in its absence (  52  ). In contrast, expression of other genes 
previously implicated in T cell suppression were not altered 
in naive   Ctla4       /         T cells as illustrated by similar transcript 
levels for the representative genes in   Fig. 6  . These results sug-
gest that CTLA-4  –  suffi   cient T reg cells indirectly prevent na-
ive   Ctla4       /         T cells from becoming fully activated, possibly 
by regulating the immune stimulatory activities of APCs. 
    Figure 6.         Expression of Gadd45     is decreased in naive   Ctla4      /        
T cells from mixed BM chimaeras relative to the WT T cells.  Semi-
quantitative RT-PCR analysis of the expression of select genes in regu-
lated   Ctla4     /       T cells from mixed BM chimaeras with inconsistent results 
from the array experiments. Threefold dilutions of cDNA prepared from 
naive (CD44      CD62L +  ) WT or   Ctla4     /       T cells were analyzed for the genes 
indicated with documented functions in T cell activation and tolerance. 
Expression of     -actin was used as loading control. Data are representa-
tive of three independent experiments.     430 T REG CELLS REQUIRE CTLA-4 FOR TRANS-REGULATION   | Friedline et al. 
the latter two model systems we have identifi  ed CTLA-4  –
  suffi   cient CD4  +  CD25  +   T reg cells as the subset necessary for 
trans-regulation of naive   Ctla4        /      T cells. Because CTLA-4  –
  defi  cient FOXP3  +   T reg cells in   Ctla4        /      mice cannot pre-
vent the lymphoproliferative disease, the results defi  nitively 
show that CTLA-4 is essential for in vivo T reg cell  –  mediated 
regulation of naive T cell activation. This function of CTLA-4 
transfer into lymphopenic mice, we have conclusively dem-
onstrated that naive   Ctla4        /      T cells are regulated in trans by 
CTLA-4  –  suffi   cient T reg cells. The fi  rst model system does 
not involve whole body irradiation, ruling out experimental 
artifacts such as a dysregulated cytokine environment in irra-
diated mice as a caveat to the physiological relevance of the 
observed   Ctla4        /      T cell homeostasis imposed in trans. Using 
    Figure 7.         Regulation of   Ctla4      /        T cells does not absolutely require signaling through the IL-10 receptor.   Rag1     /       mice received a 1:1 mix 
of 4   ×   10  6   BM cells from WT and either   Ctla4     /       or   Il10ra     /    Ctla4    /       mice. Mice were killed at 12 wk after reconstitution, and CD4  + FoxP3       (A)  or 
CD8  +   (B) splenic T cells were analyzed for the activation markers CD44 and CD62L in WT and KO T cell populations. FoxP3  +   frequency was also as-
sessed in the CD4  +   T cell subset (A, bottom). Data shown are representative fl  ow cytometric results from the spleen of reconstituted mice (three mice 
per group) in two independent experiments.     JEM VOL. 206, February 16, 2009 
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maintenance and function of T reg cells (  25, 56, 57  ). Although 
T reg cells produce TGF-    , studies have also shown that T 
reg cell  –  derived TGF-     is not essential for T cell homeostasis 
as long as other cells are capable of its production (  58  ). Fur-
ther, TGF-     has T reg cell  –  independent functions in regulat-
ing T cell development and homeostasis (  59  –  61  ). Hence, 
although FOXP3  +   T reg cells use CTLA-4 and TGF-     as ef-
fectors of immune suppression, CTLA-4 and TGF-     also 
maintain T cell homeostasis and self-tolerance in a T reg cell  –
  independent manner. Conversely, FOXP3  +   T reg cells use 
immune suppressive pathways other than CTLA-4 and TGF-
     to regulate T cell activation both in vitro and in vivo (  62  ). 
  Data presented here do not provide a defi  nitive identifi  ca-
tion of the mechanism(s) responsible for CTLA-4  +   T reg 
cell  –  mediated trans-regulation of   Ctla4        /      T cells. However, 
the fact that, (a) TGF-    , IL-10, and B7 signaling are not sin-
gularly required in   Ctla4        /      T cells, (b)   Il35   expression (  63  ) 
was normal in   Ctla4       /         T reg cells (unpublished data), and (c) 
  Ctla4       /         and WT T cells displayed highly similar global gene 
expression patterns, strongly suggests that T regs do not act 
directly on   Ctla4       /         T cells. We thus favor the hypothesis 
that T reg cells control   Ctla4       /         T cells by limiting immuno-
genicity of APCs in a noninfl  amed setting, a well-documented 
mechanism of T reg cell function in vitro (  64, 65  ) and in vivo 
(  66  ). In particular, several studies have suggested that the im-
munosuppressive enzyme IDO is produced by DCs upon 
encounter with T reg cells expressing functional CTLA-4, al-
though the in vivo requirement for IDO in T reg cell  –  medi-
ated immunosuppression has not been established (  67, 68  ). 
  There are other possible mechanisms by which   Ctla4        /      T 
cells could be maintained in a quiescent state by CTLA-4  –  suf-
fi  cient T reg cells. It has been suggested that DCs can secrete 
exosomes containing MHC and co-stimulatory molecules that 
can be transferred intercellularly to other DCs to stimulate 
T cells (  69  ). Hence, we have considered the possibility that 
CTLA-4  –  expressing T cells produce exosomes containing 
CTLA-4 that can be taken up by   Ctla4        /      T cells and used to 
intrinsically maintain regulation. We have been able to both 
detect exosomes containing CTLA-4 and transfer CTLA-4 
protein to   Ctla4        /      CD4  +   T cells in vitro, but have yet to ob-
tain any direct in vivo evidence for this mechanism in the 
mixed chimaera model (unpublished data). 
  Alternatively, because CTLA-4 has been estimated to have 
50  –  100-fold higher affi   nity to B7 than CD28, it is conceivable 
that in the mixed chimaeras CTLA-4  –  suffi   cient T cells, espe-
cially T reg cells, are competitively engaging available B7 
molecules on the APCs, thereby preventing CD28 signaling, 
and subsequent T cell activation in   Ctla4        /      T cells. Physical 
competition alone appears unlikely given that as few as 10% of 
total T cells of WT origin can control the activation of the re-
maining 90%   Ctla4       /         T cells. Nevertheless, we have ob-
served that in B7.2:  Ctla4       /         transgenic (overexpressing B7.2 
on T and B cells) mixed BM chimaeras, tolerance was not es-
tablished (unpublished data), consistent with a B7   “  competi-
tion model  ”   that predicts an increase in the probability of 
CD28 triggering in   Ctla4        /      T cells that could result in a 
is not simply restricted to controlling   Ctla4       /         T cells, be-
cause a specifi  c conditional loss of CTLA-4 in T reg cells in 
mice results in systemic lymphoproliferation whether or not 
naive T cells can express CTLA-4 (unpublished data). 
  Previous studies using mixed BM chimaeras had established 
that CTLA-4  –  suffi   cient cells can function in trans to maintain 
  Ctla4       /         T cells in a naive state (  22  ). Using the colitis model 
system, it was shown that naive B7      /       Ctla4        /      eff  ector T cells 
were prevented from causing colitis by B7      /      CTLA-4  –  suffi   -
cient T reg cells, but not by B7         /      Ctla4        /      T reg cells (  30  ). A 
major caveat to these studies was that the few T reg cells aris-
ing from B7-defi  cient mice may have altered properties caused 
by the loss of CD28 and CTLA-4 signaling during their devel-
opment (  53  ). More problematic was the observation that B7         /     
Ctla4        /      T reg cells or sorted   Ctla4        /      T reg cells from 
WT:  Ctla4        /      mixed BM chimaeras were reported to be eff  ec-
tive in regulating colitogenic CD4  +   T cells, indicating that 
CTLA-4 is in fact dispensable for T reg cell function. To ac-
count for this discrepancy, it was suggested that   Ctla4        /      T reg 
cells can adapt to the loss of CTLA-4 and use alternate, com-
pensatory mechanisms of immune suppression, such as the en-
hanced prominence of IL-10 as the suppressive factor (  25, 30  ). 
The relevance of these fi  ndings to the regulation of   Ctla4        /      
T cells in vivo was unclear because even the proposed 
  “  adapted  ”     Ctla4        /      T reg cells are incapable of regulating 
  Ctla4        /      T cells in unmanipulated   Ctla4        /      mice. Hence, the 
importance of T reg cells, or other immunoregulatory T cell 
subsets, in the control of   Ctla4        /      T cells in trans and the po-
tential regulatory mechanisms involved remained ambiguous. 
  Here, we have presented a systematic characterization of 
eff  ector T cell  –  extrinsic CTLA-4 function to maintain T cell 
tolerance. Only T reg cells expressing CTLA-4 can restrain 
the autoreactive T cells in vivo. Regulation is long-lasting, 
and depending on the persistent presence of T reg cells, is 
stable in the face of infection or immunity against alloanti-
gens. The equal participation of   Ctla4       /         and WT T cells in 
immune responses against acute or chronic pathogen infec-
tion suggests that CTLA-4 is dispensable on eff  ector T cells 
during the initiation and resolution of primary infl  ammatory 
T cell responses against foreign antigens. 
  The results, however, do not exclude T reg cell  –  indepen-
dent functions of CTLA-4 and, conversely, CTLA-4  –  inde-
pendent T reg cell eff  ector mechanisms in the maintenance of 
T cell tolerance. There are three molecules whose absence 
in vivo causes early onset, lethal lymphoproliferative disease: 
CTLA-4, FOXP3, and TGF-     (  54, 55  ). All three have im-
mune-suppressive functions and, at this point, it is unclear 
whether they are components of a single pathway or parallel 
converging pathways. Current data would suggest that both 
hypotheses may be true. We have demonstrated that FOXP3  +   
T reg cells require CTLA-4 for in vivo regulatory functions. 
However, CTLA-4 also appears to play a role in regulating 
eff  ector T cell activation independent of T reg cells because 
CTLA-4 expression targeted specifi  cally in activated conven-
tional T cells (but not naive or T reg cells) can delay fatality of 
  Ctla4       /         mice (unpublished data). TGF-     is required for the 432 T REG CELLS REQUIRE CTLA-4 FOR TRANS-REGULATION   | Friedline et al. 
  For T reg cell cotransfer studies, LN and spleen cells from healthy mixed 
BM chimaeras (  Ctla4       /      :CD90.1  +    WT) were labeled with CD90.1-biotin, 
followed by streptavidin magnetic beads, and then purifi  ed on an Auto-
MACS System (Miltenyi Biotec) to deplete WT T cells. After purifi  cation, 
T cells were typically   >  96% CD90.1       . To obtain T reg cells, LN and spleen 
cells were isolated from C57BL/6 mice, labeled with Abs against CD4 and 
CD25, and sorted on a MoFlo high-speed sorter. Sorted purity was routinely 
  >  95%, of which     90% were FOXP3  +  , as determined by intracellular stain-
ing. Cells were washed in PBS, counted, and injected i.v. (2   ×   10  7   cells/
mouse) at approximately a 10:1 ratio of WT T cell  –  depleted cells from 
mixed chimaeras to T reg cells. 
  In vivo mAb-mediated cell depletions.     Abs were purifi  ed from superna-
tants of the following hybridomas using protein G  –  Sepharose columns: anti-
CD90.1 (clone OX7), anti-NK1.1 (PK136), and anti  –  TGF-     (2G7). For WT 
T cell depletions, mice received three consecutive injections of OX7 mAb, 
followed by weekly injections to maintain depletion (0.25 mg i.p.). For NK 
depletions, mice received weekly injections of PK136 Ab (0.025 mg i.p.). For 
TGF-     blockade, mice received 0.25 mg of 2G7 Ab every 4 d. 
  Flow cytometric analysis.     Single-cell suspensions at 10  6   cells/sample 
were preincubated in 2.4G2 hybridoma supernatant to block Fc    R binding 
for 15 min, and then incubated with various combinations of the follow-
ing conjugated Abs for 30 min: Ly9.1-FITC, CD25-FITC, FoxP3-FITC, 
CD69-FITC, CD8-PE, CD62L-PE, CD4-PECy5, CD4-PerCPCy5    5, 
CD25-PECy7, CD45.1-PECy7, CD8-APCCy7, CD44-APC, CD45.1-bio-
tin, CD90.1-biotin, Streptavidin-ECD, Streptavidin-Pacifi  c Blue. Abs used 
for fl  ow cytometric analysis were purchased from BD or eBioscience. Cells 
were washed, fi  xed in 4% paraformaldehyde for 10 min, washed again, and 
then resuspended in FACS buff  er (1X PBS/1.5% FCS/0.05% NaN  3  ). Samples 
were analyzed on either an Epics XL-MCL (Beckman Coulter) or LSRII fl  ow 
cytometer (BD). For intracellular FOXP3 staining, the manufacturer  ’  s proto-
col was followed (eBioscience). For peripheral blood analyses,     50  –  100   μ  l of 
blood from the tail vein was mixed with heparin, stained with fl  uorochrome-
conjugated antibodies, briefl  y incubated in 0.25% saponin, fi  xed in 4% para-
formaldehyde for 10 min, and resuspended in FACS buff  er for analysis. At 
least 100,000 events were collected (20,000  –  50,000 events for blood) for each 
sample, and data were analyzed using FlowJo software (Tree Star, Inc.). 
  BrdU analysis.     Animals received twice daily injections of 1 mg of BrdU i.p. 
for 2 d before sacrifi  ce. After cell surface marker staining, cells were incubated 
in 50     l of 5 M NaCl, followed by the slow addition of 120     l of 95% EtOH. 
Cells were then stored at   –  20  °  C overnight, washed, and incubated in 4% 
paraformaldehyde for 20 min on ice. Subsequently, cells were incubated in 
DNase solution (1X PBS/0.05% Tween-20/125 U DNase I/sample) for 15 
min at room temperature, and then for 15 min on ice. Samples were washed 
once in PBS, once with labeling buff  er (1X PBS/2% FBS/0.05% Tween-20) 
and incubated with anti  –  BrdU-FITC (BD) for 30 min. After being washed 2 
times, cells were immediately analyzed by fl  ow cytometry. 
  Pathogen challenge.     Healthy mixed BM chimaeras 12 wk or more after re-
constitution were used for these studies. For LCMV infections, chimaeras were 
challenged i.p. with 5   ×   10  4   PFU of strain Armstrong virus. Activation status, 
T cell ratios, and antigen-specifi  c splenic T cell responses were analyzed at 
7  –  9 d after infection. For   Mtb   infection, sonicated   Mtb   Erdman stock was titrated 
to deliver     100 CFU per mouse. Mice were exposed to infectious aerosol for 
30 min in a Glass-Col inhalation Exposure System (Glass-Col, LLC). Upon 
sacrifi  ce at 6 or 14 wk after infection, mice were immediately perfused with 
PBS. Lungs were minced, digested with collagenase and DNase for 30 min at 
37  °  C, and strained, and RBCs were lysed. Spleens were also removed for 
analysis. Cells were then analyzed by fl  ow cytometry. 
  Semiquantitative RT-PCR analysis.     Naive (CD44  lo  CD62L  hi  )   Ctla4       /         
or WT CD4  +   T cells (  >  95% pure) from healthy mixed BM chimaeras 
breakdown in regulation. However, as B7.2 transgenic T cells 
are expanded and show signs of activation, the absence of reg-
ulation in these mixed chimaeras could alternatively be a direct 
consequence of aberrant T cell homeostasis in the tolerizing 
(  Ctla4  +/+    ) T cell population rather than increased access to B7 
ligands. Ongoing studies with more refi  ned cell type  –  depen-
dent, temporal manipulation of relevant co-stimulatory ligands 
and receptors will help delineate the mechanism(s) of trans-
regulation involving non-T accessory cells. 
    MATERIALS AND METHODS   
  Mice.     All mice were bred and maintained in our specifi  c pathogen  –  free ani-
mal facilities. All animal experiments were approved by the University of Mas-
sachusetts Medical School Institutional Care and Use Committee.   Ctla4       /         
mice were backcrossed for 12 generations onto the C57BL/6 background. 
CD45.1  +   or CD90.1  +   congenic C57BL/6 mice were crossed with   Ctla4  +/         
mice to generate a source of allelically distinguished   Ctla4       /         cells in chimaeras 
and during transfer experiments.   Rag1       /      , Tcrb       /        ,   Tcrd       /        ,   Cd8a        /     , and 
  Cd28        /      mice were obtained from The Jackson Laboratory.  Cd80       /      Cd86       /         
double-knockout mice (B7         /        ) were obtained from A. Sharpe (Harvard Med-
ical School, Boston, MA).   Cd4       /         mice were obtained from N. Killeen (Uni-
versity of California, San Francisco, San Francisco, CA). 2CT, OTI, and OTII 
TCR transgenic mice were provided by K. Rock (University of Massachus-
setts Medical School, Worcester, MA). IL-10R     mutant mice were generated 
by ENU mutagenesis and contain a single base mutation that results in a stop 
codon at amino acid 220 of the IL-10R     chain (unpublished data). Similar to 
  Il10       /         mice,   Il10ra  N/N     mice (referred to as   Il10ra       /         here for simplicity) suff  er 
from severe infl  ammatory bowel syndrome. The mice were backcrossed   >  10 
generations to C57BL/6 and then crossed to   Ctla4       /         mice to generate 
  Il10ra       /      Ctla4       /         double-defi  cient mice. 
  Generation of blastocyst chimaeras.     Blastocyst chimaeras were created by 
injecting   Ctla4       /         embryonic stem cells (  12  ) into C57BL/6 blastocysts and 
reimplanting the embryos into surrogate mothers. Resulting progeny were 
periodically bled over 3 yr, and the frequency of   Ctla4       /         T cells monitored 
by enumerating the percentage of Ly9.1  +   T cells (  Ctla4       /        ) versus Ly9.1        T 
cells (  Ctla4  +/+    ) via fl  ow cytometry. 
  Preparation and transfer of BM.     The femurs and tibias of donor mice were 
fl  ushed with RPMI-1640 supplemented with 5% FBS (HyClone; Invitrogen), 
sodium pyruvate,   l-  glutamine,     2-mercaptoethanol, nonessential amino acids, 
and 100 U/ml penicillin/streptomycin (R5) using a 25-gauge needle. BM was 
mechanically separated by gentle pipetting, and RBCs were removed by a 
1-min lysis step (0.15 M NH  4  Cl, 1 mM KHCO  3  , and 0.1 mM EDTA, pH 7.3). 
After lysis and washing, BM cells were resuspended in 2.5 ml of R5 and de-
pleted of T cells using anti-CD90.2 and/or a mixture of anti-CD4/CD8 –  coated 
magnetic beads (Invitrogen). BM was analyzed by fl  ow cytometry for eff  ective 
depletion of T cells (with anti  –  TCR-    -FITC), washed 2 times in PBS, and ad-
justed to 2   ×   10  7   cells/ml. Mice were sublethally irradiated (300 rads) and in-
jected with     4   ×   10  6   BM cells i.v. 4 wk after transfer, peripheral blood samples 
were obtained and analyzed for T cell reconstitution by fl  ow cytometry. 
  Cell preparation and adoptive transfer of peripheral cells.     LNs (pooled 
from superfi  cial, deep cervical, axillary, brachial, inguinal, mesenteric, and lum-
bar) and spleen were isolated and homogenized via glass slides (or using a tissue 
homogenizer for sorting experiments), and RBCs were lysed. Cells were 
washed, fi  ltered, and resuspended in R5. Transfers involving sorted CD4  +   or 
CD8  +   T cells were performed as follows: LN and spleen cells were isolated 
from WT mice or mixed BM chimaeras, pooled, labeled with fl  uorescently 
conjugated CD4 and CD8 Abs plus a congenic marker (to diff  erentiate 
  Ctla4       /         T cells in mixed chimaeras), and sorted on a MoFlo high-speed sorter 
(Dako). After sorting, cells were washed in PBS and     1   ×   10  7   total T cells were 
transferred to   Rag1       /         recipients (subsequent 1:1 mix of WT CD4  +   or CD8  +   
T cells and CD4  +     Ctla4       /         T cells injected on consecutive days after sorting). JEM VOL. 206, February 16, 2009 
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(pooled T cells from 3  –  5 mice/sort) were sorted on a MoFlo high-speed 
sorter using Abs to CD44, CD62L, and the congenic marker CD45.1. 
Cells were counted and resuspended in Trizol (Invitrogen). mRNA was 
isolated as per the manufacturer  ’  s protocol. cDNA preparation was per-
formed with the OmniScript RT kit following the manufacturer  ’  s instruc-
tions (QIAGEN). Serial dilutions of cDNA were PCR amplifi  ed using 
the  following primers:   Actb  , 5    -CTAGGCACCAGGGTGTGATGG-3     
and 5    -TCTCTTTGATGTCACGCACGA-3    ;   Cblb  , 5    -TTCCAGAT-
GGCAAATTCTATG-3     and 5    -TACATCCTTTCCTTGCCTTCT-
TTA-3    ;   Gadd45b  , 5    -TACGAGGCGGCCAAACTGATGAAT-3     and 
5    -ACCCATTGGTTATTGCCTCTGCTC-3    ;   Lklf  , 5    -CTGGAGGC-
CAAGCCCAAACGCGGC-3     and 5    -CGTTGGGGACAGTAAACT-
CAAAGGCA-3    ;   Nfatc2,    5    -TGCTGTTCTCATGGATGCCCTCAA-3     
and 5    -TCCTCTCATCTGCTGTCCCAATGA-3    ;   Pou2f1  , 5    -ACGCAC-
CAGCATAGAGACCAACAT-3     and 5    -TCACAGCAGCACTGGTTA-
AAGGGA-3    ; and   Prkcz  , 5    -TCCTTGATGCCGACGGACACATTA-3     
and 5    -GCTGGTGAACTGCGTGTCAAAGTT-3    . 
  Histological analyses.     Tissues (pancreas, small intestine, liver, lung, heart, 
tongue, and ear) were fi  xed in 10% buff  ered formalin, paraffi   n embedded, sec-
tioned, and stained with hematoxylin and eosin. Two sections, 90   μ  m apart, 
were cut from each block, and slides were viewed by light microscopy. 
  Online supplemental material.     Fig. S1 demonstrates that challenge with 
the bacterial pathogen   Mtb   does not abrogate regulation of   Ctla4       /         T cells in 
mixed BM chimaeras. Fig. S2 demonstrates that trans-regulation of   Ctla4       /         
T cells from mixed BM chimaeras is maintained in the presence of WT T cells 
upon adoptive transfer to lymphopenic hosts. Online supplemental material 
is available at http://www.jem.org/cgi/content/full/jem.20081811/DC1. 
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